Eduardo Davila

First Name*

Last Name*

Email*

Phone*

Message*

I am authorized to claim this profile. I agree Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

First Name*

Last Name*

Email*

Phone*

Message*

Eduardo Davila and Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

Contact Eduardo

Eduardo Davila

Co-Founder & Chief Scientific Officer

Trampoline Pharma

My and my research team’s aims are to understand the cellular and molecular signals that promote the generation of potent and long-lasting tumor-specific T cell responses. I oversee a translational and basic research program. Our long-term goals are to develop novel approaches for treating immunorefractory cancers and to develop predictive models and diagnostics to identify compounds that sensitize tumors to T cell-based therapies.

Talks About
#management

Preferred Locations
#Northamerica

Speaking Engagements

4th TIL Therapies Summit

Paid

Welcome to the 4th TIL Therapies Summit Commercialization looks set to propel TIL therapy into the spotlight for adoptive cell therapy, and the 4th TIL Therapies Summit arrives to finally reunite the community in-person this October.

24-26 October 2022

Healthcare

5th TIL Therapies Summit 2023

Paid

Join us at the 5th TIL Therapies Summit, where groundbreaking advancements in TIL (Tumor-Infiltrating Lymphocytes) therapy are set to revolutionize the field of cancer treatment. Hosted by industry leaders such as Iovance Biotherapeutics, Turnstone Biologics, Achilles Therapeutics, and Lyell Immunopharma, this exclusive event is the premier forum f

02-04 October 2023

Healthcare

Claim Your Profile Request

Speaker Contact Request

SPEAKER

Eduardo Davila

Co-Founder & Chief Scientific Officer

Speaking Engagements

4th TIL Therapies Summit

5th TIL Therapies Summit 2023